Myasoedova VA, Bozzi M, Valerio V, Moschetta D, Massaiu I, Rusconi V, Di Napoli D, Ciccarelli M, Parisi V, Agostoni P et al
None of the 5 patients had antibodies cross reactive to native GLP-1 or had neutralizing antibodies
Initiating titratable fixed-ratio combinations of basal insulin analogs and glucagon-like peptide-1 receptor agonists: what you need to know
Peptibodies: A flexible alternative format to antibodies
Im thrilled to share that we are now in a pilot phase testing our platform in restaurants which positions us for our anticipated launch in Q2 of 2024
PAM activity was measured in 24 heterozygous carriers of the p.S539W allele, 27 heterozygous and 21 homozygous carriers of the p.D563G allele and age, sex and BMI matched non-carriers